首页 | 本学科首页   官方微博 | 高级检索  
     


The Long-Term Effect Of Specific Type II 5α-Reductase Inhibition With Finasteride on Bone Mineral Density in Men: Results of a 4-Year Placebo Controlled Trial
Authors:ALVIN M. MATSUMOTO, LISA TENOVER, MICHAEL McCLUNG, DAVID MOBLEY, JACK GELLER, MICHAEL SULLIVAN, JOHN GRAYHACK, HUNTER WESSELLS, DOV KADMON, MALACHI FLANAGAN, GANG K. ZHANG, JOSEPH SCHMIDT, ALICE M. TAYLOR, MICHAEL LEE, JOANNE WALDSTREICHER,FOR THE PLESS STUDY GROUP&#x  
Affiliation:aFrom the VA Puget Sound Health Care System and University of Washington, Seattle, Washington, Emory University, Atlanta, Georgia, Oregon Osteoporosis Center, Portland, Oregon, Research for Health, Inc, Houston, Texas, Mercy Research Clinic, San Diego, California, Northwestern University, Chicago, Illinois, University of Arizona, Tucson, Arizona, Baylor College of Medicine, Houston, Texas, Rush Presbyterian Medical Center, Chicago, Illinois, Park Nicollet Clinic, Minneapolis, Minnesota, University of California, San Diego, California, and Merck & Co., Inc., Rahway, New Jersey
Abstract:
Keywords:prostatic hyperplasia   bone density   stanolone   finasteride
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号